Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $172 at Baird

May 3, 2023 6:33 AM
Baird analyst Jeffrey Johnson raised the price target on Zimmer Biomet (NYSE: ZBH) to $172.00 (from $145.00) while maintaining a Outperform rating.

Categories

Analyst PT Change

Next Articles